DENPRO - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,155,426 | 1,174,784 | 1,070,432 | 786,636 | 1,055,126 | 793,236 | 765,264 | 739,126 |
| Profit before tax | 95,971 | 97,792 | 217,822 | 7,664 | 54,563 | 1,479 | 684 | 27,578 |
| Net profit | 81,500 | 83,034 | 184,200 | 6,344 | 46,593 | 1,291 | 38 | 21,884 |
| Equity | 502,613 | 548,648 | 635,847 | 562,191 | 508,784 | 410,074 | 310,112 | 308,466 |
| Liabilities | 165,390 | 305,766 | 121,447 | 113,144 | 81,308 | 56,197 | 119,039 | 155,319 |
| Non-current assets | 307,327 | 320,741 | 261,195 | 230,178 | 189,119 | 136,771 | 123,003 | 75,227 |
| Current assets | 372,287 | 541,325 | 508,635 | 443,566 | 398,906 | 327,706 | 304,360 | 386,876 |
| Total assets | 679,614 | 862,066 | 769,830 | 673,744 | 588,025 | 464,477 | 427,363 | 462,103 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 124,992 | 103,452 | 118,475 |
| Social insurance contributions | - | - | - | - | - | 32,522 | 32,082 | 38,140 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +40.9% | +1.7% | -8.9% | -26.5% | +34.1% | -24.8% | -3.5% | -3.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 12.0% | 9.6% | 23.9% | 0.9% | 7.9% | 0.3% | 0.0% | 4.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 16.2% | 15.1% | 29.0% | 1.1% | 9.2% | 0.3% | 0.0% | 7.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.1% | 7.1% | 17.2% | 0.8% | 4.4% | 0.2% | 0.0% | 3.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.3% | 8.3% | 20.3% | 1.0% | 5.2% | 0.2% | 0.1% | 3.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.6 | 0.2 | 0.2 | 0.2 | 0.1 | 0.4 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 80,145 | 98,583 | 107,942 | 78,664 | 136,145 | 125,248 | 137,063 | 103,133 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
DENPRO - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-04-18 | 2023-04-19 | 631.85 |
| 2023-02-17 | 2023-02-23 | 12.49 |
| 2022-02-17 | 2022-02-20 | 113.55 |
| 2022-01-18 | 2022-01-23 | 0.01 |
| 2021-09-16 | 2021-09-16 | 9.59 |
DENPRO - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
DENPRO, UAB (code 302603270) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €739.1K, down 3.4% year on year and 6.8% over two years, indicating a gradual decline in turnover compared with 2023 and 2024. Net profit improved materially to €21.9K in 2025 from €38 in 2024 and €1.3K in 2023, showing a clear recovery in profitability after a very weak prior year. The 2025 profit margin was 3.0%, compared with 0.0% in 2024 and 0.2% in 2023. Total assets at year-end 2025 were €462.1K, with equity of €308.5K and liabilities of €155.3K. The equity ratio stood at 66.8%, and debt-to-equity was 0.50, suggesting a moderately conservative balance sheet structure. Asset turnover was 1.60x, while return on equity was 7.1% and return on assets 4.7%. Revenue per employee was €105.6K, and profit per employee €3.1K, indicating solid operating productivity despite the softer revenue trend.